drugset / Trial / NCT01121497

The Effect of Physostigmine on Cognitive Functioning in the Immediate Period After Sedation for Colonoscopy

NCT01121497

Unknown 160 enrolled Rabin Medical Center
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine whether the administration of physostigmine in combination with sedation for colonoscopy can minimize the cognitive decline at the time of hospital discharge

Timeline

Start
2010-07
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Physostigmine Small molecule 1 mg Intravenous

Indications